基于T1增强最大层面直方图分析在胶质肉瘤与胶质母细胞瘤之间的鉴别价值

doi:10.12117/jccmi.2020.02.002

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective: To study the differential diagnosis value of dynamic contrast-enhanced MRI(DCE-MRI) histogram between gliosarcoma and glioblastoma in maximum level. Methods: We collected 65 cases, which included 35 cases of glioblastoma and 30 cases of gliosarcoma. Region of interest(ROI) was drawn on the axial enhanced MR images on each layer of tumors by using Mazda software, the gray histogram was analyzed, and statistical analysis was performed on the two sets of parameters obtained from histograms. Results: After analysing the nine parameters by gray histogram, two parameters, skewness and kurtosis, showed significant difference between the two groups. The other seven parameters, including mean, variance, perc.01%, perc.10%, perc.50%, perc.90% and perc.99%, showed no statistical significance. Conclusion: Histogram analysis of DCE-MRI has diagnostic value between gliosarcoma and glioblastoma in maximum level.

Key words： Glioblastoma Magnetic resonance imaging

Received: 23 November 2018

PACS:	Ｒ739.41
	Ｒ730.264
	Ｒ445.2

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WEN Meng-meng
	ZHANG Yong
	CHENG Jing-liang
	HUANG Hui-yu

Cite this article:

WEN Meng-meng,ZHANG Yong,CHENG Jing-liang, et al. Differential diagnosis between gliosarcoma and glioblastoma based on T1-enhancement histogram analysis in maximum level[J]. JOURNAL OF CHINA MEDICAL IMAGING, 2020, 31(2): 83-86.

URL:

http://www.jccmi.com.cn/EN/10.12117/jccmi.2020.02.002 OR http://www.jccmi.com.cn/EN/Y2020/V31/I2/83

[1]Romero-Rojas AE, Diaz-Perez JA, Ariza-Serrano LM, et al. Primary gliosarcoma of the brain: radiologic and histopathologic features[J]. Neuroradiol J, 2013, 26(6): 639-648.
[2]Kozak KR, Mahadevan A, Moody JS. Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome[J]. Neuro Oncol, 2009, 11(2): 183-189.
[3]Meena US, Sharma S, Chopra S, et al. Gliosarcoma: A rare variant of glioblastoma multiforme in paediatric patient: Case report and review of literature[J]. World J Clin Cases, 2016, 4(9): 302-305.
[4]Han SJ, Yang I, Tihan T, et al. Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity[J]. J Neurooncol, 2010, 96(3): 313-320.
[5]deCarvalho AC, Nelson K, Lemke N, et al. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo[J]. Stem Cells, 2010, 28(2): 181-190.
[6]Han SJ, Yang I, Ahn BJ, et al. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients[J]. Cancer, 2010, 116(5): 1358-1366.
[7]Staff RT, Gemmell HG, Sharp PF, et al. Assessment of energy-weighted acquisition in SPECT using ROC analysis[J]. J Nucl Med, 1995, 36(12): 2352-2355.
[8]Ulyte A, Katsaros VK, Liouta E, et al. Prognostic value of preoperative dynamic contrast-enhanced MRI perfusion parameters for high-grade glioma patients[J]. Neuroradiology, 2016, 58(12): 1197-1208.
[9]Schoenegger K, Oberndorfer S, Wuschitz B, et al. Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma[J]. Eur J Neurol, 2009, 16(7): 874-878.
[10]王相国，江涛，艾林，等. 胶质肉瘤和胶质母细胞瘤的常规MRI比较研究[J]. 医学影像学杂志，2013，23（6）：828-830.
[11]Gihr GA, Horvath-Rizea D, Kohlhof-Meinecke P, et al. Histogram Profiling of Postcontrast T1-Weighted MRI Gives Valuable Insights into Tumor Biology and Enables Prediction of Growth Kinetics and Prognosis in Meningiomas[J]. Transl Oncol, 2018, 11(4): 957-961.
[12]刘杨颖秋，尚劲，田诗云，等. 利用肿瘤全域表观扩散系数信号强度直方图鉴别Ⅱ级与Ⅲ级胶质瘤[J]. 磁共振成像杂志，2017，8（4）：276-282.